Binding of MMP13 to Immune Checkpoint Receptor PD-1H links Bone Disease with Immune Suppression in Multiple Myeloma
Binding of MMP13 to Immune Checkpoint Receptor PD-1H links Bone Disease with Immune Suppression in Multiple Myeloma
批准号:
10472671
负责人:
Jing Fu
金额:
$46.91万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-20 至 2026-07-31
关键词:
AddressAdoptive TransferAntigen-Presenting CellsBindingBone DiseasesBone ResorptionCell LineageCellsCytoskeletal ModelingCytoskeletonDevelopmentDiseaseDisease ProgressionDisease remissionDoseEnvironmentGoalsGrantHandHematopoieticHomologous GeneHumanImmuneImmune Cell SuppressionImmune responseImmunologic SurveillanceImmunosuppressionIn VitroIntegral Membrane ProteinKnock-outLesionLinkLyticMalignant NeoplasmsMatrix MetalloproteinasesMediatingMetalloproteasesMixed Lymphocyte Culture TestModelingMultiple MyelomaMusOsteoclastsPathologicPathway interactionsPatientsPhenotypePlayPopulationProteinsReceptor SignalingRegulationResearchRoleSignal PathwaySignal TransductionT-LymphocyteTestingTimeTumor-infiltrating immune cellsWorkantigen-specific T cellsbonecheckpoint receptorscollagenase 3healingimmune checkpointin vivoin vivo Modelknock-downmouse modelnovelosteoclast activating factorprofiles in patientsprogrammed cell death protein 1receptorskeletaltreatment strategy
中文摘要
多发性骨髓瘤(MM)骨疾病仍然是这种仍然无法治愈的最可怕的并发症之一
癌MM细胞产生的破骨细胞激活因子诱导破骨细胞,导致骨过度增生,
吸收和溶解性骨病变,约80%的患者愈合不良,即使在疾病缓解后。
为了筛选激活破骨细胞的潜在骨髓瘤源性因子,我们鉴定了基质金属蛋白酶(MMP-9)。
基质金属蛋白酶13(MMP-13)由原代MM细胞高度分泌,并在骨转移患者中升高
疾病MMP-13剂量依赖性地诱导广泛的骨吸收在体外和体内。在MM骨病中
在小鼠模型中,MM细胞中MMP-13的敲低显著抑制了溶解性骨损伤的发展,
证实MMP-13对于多发性骨髓瘤骨疾病的发展是关键的。特别令人
MMP-13依赖性破骨细胞活化独立于其酶活性发生,
在骨吸收的调节中建立新的范例。总之,我们已经表明MMP-13
在MM诱导的骨破坏中起关键作用。
我们现在有令人信服的证据表明,免疫检查点蛋白程序性死亡-1同源物(PD-1H),
广泛表达于各种造血细胞谱系的跨膜蛋白,作为
以前未识别的MMP-13信号受体。我们发现Pd-1h敲除在破骨细胞块中,
MMP-13诱导破骨细胞活化和骨吸收,提示MMP-13与PD-1H的结合起着重要作用。
在MM诱导的骨病中起关键作用。此外,我们发现MMP-13具有PD-1H介导的抑制作用,
对T细胞扩增的影响。MMP-13-/-抗原提呈细胞在体外具有增强的刺激能力,
体外同种异体反应性T细胞。在同种异体反应性的体内模型中,供体T细胞在Mmp-1中扩增显著更多。
13-/-受体,证实宿主MMP-13表达减轻了T细胞的扩增。
该授权的中心假设是PD-1H是MMP-13信号传导的关键受体,并介导
其对破骨细胞、抗原呈递细胞和T细胞的作用,导致骨吸收,
我们提出了以下4个目的:1)将PD-1H的作用定义为MMP-13,
2)表征MMP-13/PD-1H轴在骨骼重塑和MM骨中的作用
3)研究MMP-13/PD-1H轴作为MM中免疫检查点的作用;和4)证实MMP-13/PD-1H轴在MM中的作用。
MMP-13/PD-1H轴在MM骨疾病和MM患者免疫抑制中的作用。我们的发现
强调了一种以前未被认识到新的涉及MMP-13/PD-1H轴的破骨细胞活化途径
我们建议我们的工作将为新的研究奠定基础。
与免疫应答抑制相关的MM骨病的治疗策略。而且这
研究将有助于更好地了解MM骨病和骨髓瘤免疫之间的相互作用,
环境
英文摘要
Multiple Myeloma (MM) bone disease remains one of the most dreaded complications of this still incurable
cancer. Osteoclast-activating factors produced by MM cells induce osteoclasts, cause excessive bone
resorption, and lytic bone lesions in ~80% of patients with poor healing even after achieving disease remission.
In an effort to screen for potential myeloma-derived factors that activate osteoclasts, we identified matrix
metalloproteinase 13 (MMP-13) to be highly secreted by primary MM cells and elevated in patients with bone
disease. MMP-13 dose-dependently induces extensive bone resorption in vitro and in vivo. In MM bone disease
mouse models, MMP-13 knockdown in MM cells significantly inhibits the development of lytic bone lesions,
confirming that MMP-13 is critical for the development of multiple myeloma bone disease. It is of particular
importance that MMP-13-dependent osteoclast activation occurs independently of its enzymatic activity, thereby
establishing a new paradigm in the regulation of bone resorption. In overview, we have shown that MMP-13
plays a pivotal role in MM-induced bone destruction.
We now have compelling evidence that immune checkpoint protein programmed death-1 homolog (PD-1H), a
transmembrane protein broadly expressed on various hematopoietic cell lineages, serves as a
previously unrecognized signaling receptor for MMP-13. We found that Pd-1h knockout in osteoclast blocks
MMP-13-induced osteoclast activation and bone resorption, suggesting that MMP-13 binding to PD-1H plays a
critical role in MM induced bone disease. Furthermore, we show that MMP-13 has a PD-1H mediated inhibitory
effect on T cell expansion. Mmp-13-/- antigen presenting cells have increased stimulatory capacity on
alloreactive T cells in vitro. In an in vivo model of alloreactivity, donor T cells expand significantly more in Mmp-
13-/- recipients, confirming that host MMP-13 expression mitigates the expansion of T cells.
It is the central hypothesis of this grant that PD-1H is the key receptor for MMP-13 signaling and mediates
its effects on osteoclasts, antigen presenting cells and T cells, resulting in bone resorption and
immunosuppression in MM. We propose the following 4 Aims: 1) Define the role of PD-1H as the MMP-13
receptor in osteoclasts; 2) Characterize the role of the MMP-13/PD-1H axis in skeletal remodeling and MM bone
disease; 3) Investigate the role of the MMP-13/PD-1H axis as an immune checkpoint in MM; and 4) Confirm the
role of MMP-13/PD-1H axis in MM bone disease and immunosuppression in MM patients. Together, our findings
highlight a previously unrecognized and new pathway of osteoclasts activation involving MMP-13/PD-1H axis
that links the bone disease with immunosuppression in MM. We propose that our work will form the basis for novel
treatment strategies in MM bone disease associated with suppressed immune response. Furthermore, this
research will help to better understand the interaction between MM bone disease and the myeloma immune
environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Binding of MMP13 to Immune Checkpoint Receptor PD-1H links Bone Disease with Immune Suppression in Multiple Myeloma
-
批准号:10299234
-
项目类别:
-
资助金额:$49.42万
-
财政年份:2021
-
负责人:Jing Fu
-
依托单位:
Binding of MMP13 to Immune Checkpoint Receptor PD-1H links Bone Disease with Immune Suppression in Multiple Myeloma
-
批准号:10678676
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2021
-
负责人:Jing Fu
-
依托单位:
海外基金